	Wearable technologies for perioperative recovery monitoring in lung cancer surgery: a systematic review of feasibility, recovery outcomes, and evidence certainty. Front Oncol Lin X, Zhang J, Wang B, Dong Z, Tong Y, Zhou J, Liao H. PMID: 42318462 [PubMed]
	Integrated metabolomics and machine learning identify predictive biomarkers via SHAP analysis for sintilimab-induced rash in lung cancer patients. Front Pharmacol Tian W, Tang H, Liu X, Lv J, Xu Y, Hua Y, Xie F, Ding Y. PMID: 42318346 [PubMed]
	Mycophenolate mofetil for corticosteroid-resistant immune-related cystitis associated with tislelizumab: a case report. Front Immunol Kong L, Meng F, Yang J, Tang K, Xu J, Zhong D, Zhang L. PMID: 42317347 [PubMed - indexed for MEDLINE]
	Efficacy and mechanisms of immune checkpoint inhibitors in late-stage EGFR-mutated non-small cell lung cancer following targeted therapy resistance. Front Immunol Niu J, Jing W, Liu Z, Si Y, Liu Z. PMID: 42317338 [PubMed - indexed for MEDLINE]
	Effect of histology on the efficacy of first-line immune checkpoint inhibitors in advanced non-small cell lung cancer: a systematic review and network meta-analysis. Front Immunol Li S, He T, Chen J, Liu T, Zhao X, Dang J. PMID: 42317330 [PubMed - indexed for MEDLINE]
	Clinical exploration of first-line therapy in metastatic lung adenocarcinoma patients with negative or low PD-L1 expression: a retrospective cohort study. Front Immunol Xu K, Cai R, Sun Z, Wang C, Bao J. PMID: 42317329 [PubMed - indexed for MEDLINE]
	Clinical Factors Associated With Non-Completion of Durvalumab Maintenance Therapy After Chemoradiotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Single-Center Retrospective Study. Thorac Cancer Kotake M, Watanabe S, Sakai Y, Kikuchi T, Toyama A. PMID: 42316436 [PubMed - indexed for MEDLINE]
	Analysis of factors influencing hospitalization cost and medical security level of patients with bronchial and pulmonary malignant tumors - a retrospective study in Changzhi, China. BMC Health Serv Res Ren Y, Lei D, Gao Y, Wang C, Yang J. PMID: 42316139 [PubMed - as supplied by publisher]
	Comparative efficacy of total en-bloc spondylectomy and separation surgery followed by stereotactic body radiotherapy for isolated spinal metastases in lung cancer patients: a retrospective study. BMC Surg Zhu Z, Yuan H, Shen Z, Liu H, Li B, Xu W. PMID: 42316097 [PubMed - as supplied by publisher]
	Differentiating sub-centimeter lung metastases in colorectal cancer by deep learning: a multicenter retrospective study. BMC Med Imaging Gao X, Ma X, Zhang Z, Yuan J, Li Q, Zheng P, Lv M, Ma D, Sun J. PMID: 42316047 [PubMed - as supplied by publisher]
	The multi-omics landscape of lung adenocarcinoma evolution: deciphering metabolic reprogramming-driven immune escape and its implications in combined therapy. Cell Death Discov Liu N, Han G, Jia J, Chen M. PMID: 42315853 [PubMed - as supplied by publisher]
	Integrating Structured Expert Elicitation with External Evidence to Inform Earlier Reimbursement Decisions: A Norwegian Case Study of Selpercatinib for Non-Small Cell Lung Cancer. Pharmacoecon Open Wu YS, Burger EA, Holmboe F, Bangum M, Oteiza F, Bugge C, Sæther EM, Aas E. PMID: 42315785 [PubMed - as supplied by publisher]
	Correlative assessment of p53 immunostaining patterns andÂ TP53 mutation status by next-generation sequencing inÂ lung adenocarcinoma (LUAD). Histopathology Zhang Y, Zheng K, Tang Y, Yang K, Chen Z, Li Y, Zhang Y, Zhang G, Qiu L, Peng R, Liu X, Jiang L. PMID: 42315496 [PubMed - as supplied by publisher]
	Journey Mapping of the Patient Experience from Diagnosis to End of Life in Lung Cancer: A Qualitative Meta-Synthesis. Semin Oncol Nurs Zhang F, Wang Y, Xiao Y, Li J, Liu Y, Li H, Wang Z, Li W. PMID: 42315410 [PubMed - as supplied by publisher]
	Mitochondrial DNA in Lung Cancer: from biology to clinical implications. Crit Rev Oncol Hematol Lucio-Lozada J, Prada D, Beato-González L, Hirsch FR, Cardona AF, Hernández-Pedro N, Arrieta O. PMID: 42314881 [PubMed - as supplied by publisher]
	Prospective study of proton beam therapy for non-small cell lung cancer patients with idiopathic pulmonary fibrosis. Radiother Oncol Shin H, Yang K, Yoo H, Park HY, Shin SH, Noh JM, Pyo H. PMID: 42314836 [PubMed - as supplied by publisher]
	Off-Protocol Radiotherapy in Prospective Systemic Therapy Trials for Metastatic Non-Small Cell Lung Cancer. Clin Lung Cancer Ruicci KM, Li GJ, Warner A, Youssef A, Parmar A, Mutsaers A, Palma DA, Louie AV. PMID: 42314501 [PubMed - as supplied by publisher]
	Corrigendum to "POU2F3 in Small Cell Lung Cancer (SCLC): Diagnostic Utility in Neuroendocrine-Low/Negative SCLC and Discrimination From Other Thoracic Malignancies and Other Small Blue Round Cell Tumors" [Laboratory Investigation 2026;106(6):106124]. Lab Invest Chen X, Zou F, Xu H, Zhang Z, Wang J, Li Y, Jia J, Sun S, Wang C, Zhang J. PMID: 42314383 [PubMed - as supplied by publisher]
	Mapping the evidence of stereotactic body radiotherapy combined with systemic therapy in oligometastatic and oligoprogressive non-small cell lung cancer: A visual synthesis of clinical outcomes and toxicity. Cancer Treat Res Commun Karagiannis V, Tolia M, Vomvas D, Mazonakis M, Shiarli AM, Saarinen J, Nåhls NS, Ntaskagiannis D, Morfo G, Jekunen A. PMID: 42314262 [PubMed - as supplied by publisher]
	Optimized Simultaneous N/O-Glycopeptide Enrichment Strategy Identifies Lung Cancer Diagnostic Biomarkers in Serum. J Proteome Res Zhou Z, Zhao J, Zhang J, Wu P, Yang Y, Li W, Peng C, Qiang Z. PMID: 42313501 [PubMed - as supplied by publisher]

Articles 1 - 20 / 160613

Page 1 of 8031



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy